SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001136261-18-000269
Filing Date
2018-10-22
Accepted
2018-10-22 17:14:36
Documents
2
Period of Report
2018-10-17
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K body8k.htm 8-K 11865
2 LOGO image1904.jpg GRAPHIC 6415
  Complete submission text file 0001136261-18-000269.txt   22095
Mailing Address 10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960
Business Address 10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960 (862) 260-8457
PERNIX THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001024126 (see all company filings)

IRS No.: 330724736 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14494 | Film No.: 181132809
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences